Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | ||
| Net Income | -8,084 | N/A |
| Depreciation Amortization | 328 | N/A |
| Other Working Capital | -1,020 | N/A |
| Other Operating Activity | 3,700 | 0 |
| Operating Cash Flow | $-5,076 | $N/A |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $0 | $N/A |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 5,230 | 0 |
| Financing Cash Flow | $5,230 | $N/A |
| Beginning Cash Position | 175 | N/A |
| End Cash Position | 329 | N/A |
| Net Cash Flow | $154 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -5,076 | N/A |
| Free Cash Flow | -5,076 | 0 |